FDA discussing future of COVID-19 booster shots in the fall

FDA logo
Posted at 11:59 AM, Apr 06, 2022
and last updated 2022-04-06 12:59:35-04

The FDA is meeting with a panel of outside experts Wednesday to discuss whether future booster doses should be changed.

The FDA said during its meeting that current COVID-19 vaccines are not well-matched against BA.2, a subvariant of omicron.

However, the agency did reiterate that evidence shows booster shots protect people even more from developing serious COVID-19 cases, compared with the two preliminary doses.

FDA vaccine chief, Dr. Peter Marks warned that fall weather could raise the risk of COVID-19 surges later this year.

The FDA is not expected to make any decisions during Wednesday’s meeting, but the agency could authorize another booster dose in the fall.

Coronavirus Resources and Information

Johns Hopkins global coronavirus tracker